Carbutamide

From WikiProjectMed
Jump to navigation Jump to search
Carbutamide
Carbutamide.svg
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral
ATC code
Identifiers
  • 4-amino-N-(butylcarbamoyl)benzenesulfonamide
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.005.841 Edit this at Wikidata
Chemical and physical data
FormulaC11H17N3O3S
Molar mass271.33 g·mol−1
3D model (JSmol)
  • O=S(=O)(c1ccc(N)cc1)NC(=O)NCCCC
  • InChI=1S/C11H17N3O3S/c1-2-3-8-13-11(15)14-18(16,17)10-6-4-9(12)5-7-10/h4-7H,2-3,8,12H2,1H3,(H2,13,14,15) ☒N
  • Key:VDTNNGKXZGSZIP-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Carbutamide (brand name Glucidoral) is an anti-diabetic drug of the sulfonylurea class, developed by Servier.

It is classified as first-generation.[1]

It was patented in 1953 and approved for medical use in 1956.[2]

See also

References

  1. ^ Ballagi-Pordány G, Köszeghy A, Koltai MZ, Aranyi Z, Pogátsa G (January 1990). "Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds". Diabetes Res. Clin. Pract. 8 (2): 109–14. doi:10.1016/0168-8227(90)90020-T. PMID 2106423.
  2. ^ Fischer, Jnos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 449. ISBN 9783527607495.